A study conducted in patients with type 2 diabetes receiving dulaglutide has shown that fasting blood glucose levels 2 weeks after beginning treatment are predictive of long-term glucose control as measured by HbA1c 6 months later….
Read the Rest

Tags: glucose, weeks, hba1c, blood, fasting, dulaglutide,

Page Information

  • Keywords: diabetes, diabetes newsletter, diabetic newsletter, diabetes, news for diabetics, news for doctors, diabetes in children, diabetes in control, health, blood sugars, diabetes type 1, diabetes type 2, health care, blood sugars, low blood sugars, lower blood sugars, a1cnow, hba1c, hemoglobin a1c, sportbrain, tacticon, diabetes care, pharmacy
  • Description: Diabetes In Control is a free weekly diabetes newsletter dedicated to helping medical professionals in diabetes care better help their diabetes patients.